# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 24, "Diabetes Metab Res Rev .", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasJournal> \"Diabetes Metab Res Rev .\"."
1, PublicationYear, 25, 29, "2014", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasPublicationYear> \"2014\"."
75312, Lixisenatide, 90, 102, "Lixisenatide", "", 
28, Title, 90, 310, "Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea : a randomized , double - blind , placebo - controlled ,", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasTitle> \"Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea : a randomized , double - blind , placebo - controlled ,\"."
15, Type2Diabetes, 163, 187, "type 2 diabetes mellitus", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
18, Metformin, 215, 224, "metformin", "", 
21, Sulfonylureas, 241, 253, "sulfonylurea", "", 
24, Randomized, 258, 268, "randomized", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
25, DoubleBlind, 271, 285, "double - blind", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
26, Placebo, 288, 295, "placebo", "", 
27, Duration, 311, 320, "24 - week", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasCTduration> \"24 - week\"."
29, Title, 311, 351, "24 - week trial ( GetGoal - M - Asia ) .", "", 
30, Author, 352, 360, "Yu Pan C", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Yu Pan C\"."
31, Author, 369, 374, "Han P", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Han P\"."
32, Author, 377, 382, "Liu X", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Liu X\"."
33, Author, 385, 390, "Yan S", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Yan S\"."
34, Author, 393, 399, "Feng P", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Feng P\"."
35, Author, 402, 408, "Zhou Z", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Zhou Z\"."
36, Author, 411, 415, "Lv X", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Lv X\"."
37, Author, 418, 424, "Tian H", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Tian H\"."
38, Author, 427, 436, "Jin Kui Y", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Jin Kui Y\"."
39, Author, 439, 443, "Su B", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Su B\"."
40, Author, 446, 453, "Shang S", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Shang S\"."
41, Author, 456, 468, "Niemoeller E", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasAuthor> \"Niemoeller E\"."
42, China, 562, 567, "China", "", 
45, ObjectiveDescription, 583, 812, "This study assessed the efficacy and safety of the once - daily glucagon - like peptide - 1 receptor agonist , lixisenatide , in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin  ±  sulfonylurea .", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasObjectiveDescription> \"This study assessed the efficacy and safety of the once - daily glucagon - like peptide - 1 receptor agonist , lixisenatide , in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin  ±  sulfonylurea .\"."
43, Frequency, 634, 646, "once - daily", "", 
75310, Lixisenatide, 694, 706, "lixisenatide", "", "<http://ctro/data#Medication_55870> <http://ctro/data#hasDrug> <http://ctro/data#Lixisenatide>."
106270, Ethnicity, 712, 717, "Asian", "", "<http://ctro/data#Ethnicity_55834> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity>. <http://ctro/data#Population_55832> <http://ctro/data#hasEthnicity> <http://ctro/data#Ethnicity_55834>."
44, Precondition, 712, 810, "Asian patients with type 2 diabetes mellitus inadequately controlled on metformin  ±  sulfonylurea", "", "<http://ctro/data#Population_55832> <http://ctro/data#hasPrecondition> \"Asian patients with type 2 diabetes mellitus inadequately controlled on metformin  ±  sulfonylurea\"."
16, Type2Diabetes, 732, 756, "type 2 diabetes mellitus", "", 
20, Metformin, 784, 793, "metformin", "", 
22, Sulfonylureas, 798, 810, "sulfonylurea", "", 
46, Duration, 831, 840, "24 - week", "", 
47, DoubleBlind, 843, 857, "double - blind", "", 
48, Placebo, 860, 867, "placebo", "", 
53, Multicenter, 883, 896, "multinational", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
54, Randomized, 919, 929, "randomized", "", 
75311, Lixisenatide, 933, 945, "lixisenatide", "", 
55, DoseValue, 946, 948, "20", "", "<http://ctro/data#Medication_55870> <http://ctro/data#hasDoseValue> \"20\"."
56, Microgram, 949, 952, "µ g", "", "<http://ctro/data#Medication_55870> <http://ctro/data#hasDoseUnit> <http://ctro/data#Microgram>."
57, Frequency, 953, 963, "once daily", "", "<http://ctro/data#Intervention_55858> <http://ctro/data#hasFrequency> \"once daily\"."
49, Placebo, 967, 974, "placebo", "", "<http://ctro/data#Medication_55877> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
58, HbA1c, 1021, 1041, "glycated haemoglobin", "", 
59, HbA1c, 1044, 1049, "HbA1c", "", 
61, TimePoint, 1057, 1065, "baseline", "", 
62, TimePoint, 1069, 1076, "week 24", "", 
63, NumberPatientsCT, 1100, 1103, "391", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasNumberPatientsCT> \"391\"."
64, Randomized, 1118, 1128, "randomized", "", 
75298, Lixisenatide, 1131, 1143, "Lixisenatide", "", 
60, HbA1c, 1166, 1171, "HbA1c", "", "<http://ctro/data#Endpoint_55928> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
50, Placebo, 1193, 1200, "placebo", "", 
169, LeastSquaresMean, 1203, 1210, "LS mean", "", "<http://ctro/data#Endpoint_55928> <http://ctro/data#hasAggregationMethod> <http://ctro/data#LeastSquaresMean>."
65, DiffGroupAbsValue, 1224, 1232, "- 0 . 36", "", "<http://ctro/data#DiffBetweenGroups_55987> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 36\"."
66, Percentage, 1233, 1234, "%", "", "<http://ctro/data#Endpoint_55928> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
67, PvalueDiff, 1237, 1251, "p  =  0 . 0004", "", "<http://ctro/data#DiffBetweenGroups_55987> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 0004\"."
75299, Lixisenatide, 1293, 1305, "lixisenatide", "", 
69, HbA1c_target, 1334, 1356, "HbA1c targets of < 7 %", "", "<http://ctro/data#Endpoint_55996> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
74804, Percentage, 1355, 1356, "%", "", 
74806, PvalueDiff, 1359, 1372, "p  =  0 . 003", "", "<http://ctro/data#DiffBetweenGroups_56114> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 003\"."
72, HbA1c_target, 1379, 1388, "≤ 6 . 5 %", "", "<http://ctro/data#Endpoint_56001> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
175, Percentage, 1387, 1388, "%", "", 
177, PvalueDiff, 1391, 1404, "p  =  0 . 001", "", "<http://ctro/data#DiffBetweenGroups_56123> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 001\"."
51, Placebo, 1414, 1421, "placebo", "", 
75300, Lixisenatide, 1424, 1436, "Lixisenatide", "", 
80, ObservedResult, 1441, 1494, "associated with a statistically significant reduction", "", 
73, PostprandialPlasmaGlucose, 1498, 1531, "2 - h postprandial plasma glucose", "", "<http://ctro/data#Endpoint_56132> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialPlasmaGlucose>."
52, Placebo, 1570, 1577, "placebo", "", 
183, LeastSquaresMean, 1580, 1587, "LS mean", "", "<http://ctro/data#Endpoint_56132> <http://ctro/data#hasAggregationMethod> <http://ctro/data#LeastSquaresMean>."
75, DiffGroupAbsValue, 1601, 1609, "- 4 . 28", "", "<http://ctro/data#DiffBetweenGroups_56250> <http://ctro/data#hasDiffGroupAbsValue> \"- 4 . 28\"."
76, Millimoles_per_litre, 1610, 1618, "mmol / L", "", "<http://ctro/data#Endpoint_56132> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre>."
77, PvalueDiff, 1621, 1635, "p  <  0 . 0001", "", "<http://ctro/data#DiffBetweenGroups_56250> <http://ctro/data#hasPvalueDiff> \"p  <  0 . 0001\"."
81, ObservedResult, 1644, 1665, "significant reduction", "", "<http://ctro/data#Outcome_56196> <http://ctro/data#hasObservedResult> \"significant reduction\"."
78, FastingPlasmaGlucose, 1669, 1691, "fasting plasma glucose", "", "<http://ctro/data#Endpoint_56137> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
188, PvalueDiff, 1694, 1708, "p  =  0 . 0109", "", "<http://ctro/data#DiffBetweenGroups_56259> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 0109\"."
82, BodyWeight, 1740, 1746, "weight", "", 
83, Placebo, 1759, 1766, "placebo", "", 
84, BodyWeight, 1796, 1807, "body weight", "", "<http://ctro/data#Endpoint_56268> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
75303, Lixisenatide, 1835, 1847, "lixisenatide", "", 
85, Reduction, 1852, 1858, "1 . 50", "", "<http://ctro/data#Outcome_56273> <http://ctro/data#hasChangeValue> \"1 . 50\"."
88, Kg, 1859, 1861, "kg", "", "<http://ctro/data#Endpoint_56268> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
87, Placebo, 1864, 1871, "placebo", "", 
86, Reduction, 1876, 1882, "1 . 24", "", "<http://ctro/data#Outcome_56300> <http://ctro/data#hasChangeValue> \"1 . 24\"."
89, Kg, 1883, 1885, "kg", "", 
90, PvalueDiff, 1888, 1901, "p  =  0 . 296", "", "<http://ctro/data#DiffBetweenGroups_56327> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 296\"."
91, EndPointDescription, 1923, 1958, "treatment - emergent adverse events", "", "<http://ctro/data#EndPointDescription_56337> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_56336> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_56337>."
92, EndPointDescription, 1961, 1966, "TEAEs", "", 
95, PercentageAffected, 1973, 1979, "64 . 3", "", "<http://ctro/data#Outcome_56341> <http://ctro/data#hasPercentageAffected> \"64 . 3\"."
75308, Lixisenatide, 1987, 1999, "lixisenatide", "", 
96, PercentageAffected, 2007, 2013, "47 . 4", "", "<http://ctro/data#Outcome_56368> <http://ctro/data#hasPercentageAffected> \"47 . 4\"."
99, Placebo, 2021, 2028, "placebo", "", 
202, EndPointDescription, 2036, 2049, "serious TEAEs", "", "<http://ctro/data#EndPointDescription_56396> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_56395> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_56396>."
97, PercentageAffected, 2062, 2067, "1 . 5", "", "<http://ctro/data#Outcome_56400> <http://ctro/data#hasPercentageAffected> \"1 . 5\"."
98, PercentageAffected, 2077, 2082, "2 . 1", "", "<http://ctro/data#Outcome_56427> <http://ctro/data#hasPercentageAffected> \"2 . 1\"."
94, EndPointDescription, 2130, 2134, "TEAE", "", 
75306, Lixisenatide, 2142, 2154, "lixisenatide", "", 
102, Nausea, 2165, 2171, "nausea", "", "<http://ctro/data#Endpoint_56454> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Nausea>."
104, PercentageAffected, 2174, 2180, "16 . 3", "", "<http://ctro/data#Outcome_56459> <http://ctro/data#hasPercentageAffected> \"16 . 3\"."
105, PercentageAffected, 2186, 2191, "2 . 6", "", "<http://ctro/data#Outcome_56486> <http://ctro/data#hasPercentageAffected> \"2 . 6\"."
106, Placebo, 2199, 2206, "placebo", "", 
107, SymptomaticHypoglycemia, 2228, 2253, "symptomatic hypoglycaemia", "", "<http://ctro/data#Endpoint_56513> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia>."
108, PercentageAffected, 2258, 2263, "5 . 6", "", "<http://ctro/data#Outcome_56518> <http://ctro/data#hasPercentageAffected> \"5 . 6\"."
75307, Lixisenatide, 2271, 2283, "lixisenatide", "", 
109, PercentageAffected, 2298, 2303, "2 . 6", "", "<http://ctro/data#Outcome_56545> <http://ctro/data#hasPercentageAffected> \"2 . 6\"."
111, Placebo, 2311, 2318, "placebo", "", 
112, PvalueDiff, 2321, 2335, "p  =  0 . 1321", "", "<http://ctro/data#DiffBetweenGroups_56572> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 1321\"."
113, ObservedResult, 2340, 2347, "with no", "", "<http://ctro/data#Outcome_56586> <http://ctro/data#hasObservedResult> \"with no\". <http://ctro/data#Outcome_56586> <http://ctro/data#hasObservedResult> \"events reported\". <http://ctro/data#Outcome_56613> <http://ctro/data#hasObservedResult> \"with no\". <http://ctro/data#Outcome_56613> <http://ctro/data#hasObservedResult> \"events reported\"."
220, SevereHypoglycemia, 2348, 2380, "severe symptomatic hypoglycaemia", "", "<http://ctro/data#Endpoint_56581> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SevereHypoglycemia>."
113, ObservedResult, 2381, 2396, "events reported", "", "<http://ctro/data#Outcome_56586> <http://ctro/data#hasObservedResult> \"events reported\". <http://ctro/data#Outcome_56613> <http://ctro/data#hasObservedResult> \"events reported\"."
116, ConclusionComment, 2413, 2624, "In Asian patients with type 2 diabetes mellitus insufficiently controlled on metformin  ±  sulfonylurea , lixisenatide significantly improved glycaemic control and was well tolerated during the 24 - week study .", "", "<http://ctro/data#ClinicalTrial_55816> <http://ctro/data#hasConclusionComment> \"In Asian patients with type 2 diabetes mellitus insufficiently controlled on metformin  ±  sulfonylurea , lixisenatide significantly improved glycaemic control and was well tolerated during the 24 - week study .\"."
17, Type2Diabetes, 2436, 2460, "type 2 diabetes mellitus", "", 
19, Metformin, 2490, 2499, "metformin", "", 
23, Sulfonylureas, 2504, 2516, "sulfonylurea", "", 
75309, Lixisenatide, 2519, 2531, "lixisenatide", "", 
115, Duration, 2607, 2616, "24 - week", "", 
117, PMID, 2765, 2773, "24639432", "", "<http://ctro/data#Publication_55809> <http://ctro/data#hasPMID> \"24639432\"."
